CAMPBELL NEWMAN ASSET MANAGEMENT INC

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 874791 MILWAUKEE, WI

Position in CPRX

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$3,038,966

+$749,261 QoQ

Shares Held

96,690

+4.6% QoQ

Ownership

0.079%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#10

of 75 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 18% Shared 0% None 82%

Healthcare · as of Jun 30, 2026

CAMPBELL NEWMAN ASSET MANAGEMENT INC holds $7,564,809 across 3 Biotechnology names. CPRX ranks #1 (40.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc. This page	96,690	$3,038,966
2	HALO	Halozyme Therapeutics, Inc.	37,774	$2,956,570
3	CORT	Corcept Therapeutics Inc	18,048	$1,569,273

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,038,966	96,690	+4.6%	Shares	Sole	2026-07-21
2026-03-31	$2,289,705	92,476	+1.7%	Shares	Sole	2026-04-16
2025-12-31	$2,122,002	90,917	-3.7%	Shares	Sole	2026-01-26
2025-09-30	$1,859,010	94,366	+0.4%	Shares	Sole	2025-10-23
2025-06-30	$2,039,105	93,968	+7.1%	Shares	Sole	2025-07-17
2025-03-31	$2,127,573	87,735	-0.4%	Shares	Sole	2025-04-16
2024-12-31	$1,839,168	88,125	-0.2%	Shares	Sole	2025-01-14
2024-09-30	$1,756,258	88,343	-1.6%	Shares	Sole	2024-10-15
2024-06-30	$1,390,738	89,783	+0.3%	Shares	Sole	2024-07-18
2024-03-31	$1,426,183	89,472	—	Shares	Sole	2024-04-16
No filing history on record for this holder in this stock.